Evidence map›Paper›PMID 28877478›Full record

ArticleCell reports2017

The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI.

Sandro Goruppi, Maria-Giuseppina Procopio, Seunghee Jo, Andrea Clocchiatti, Victor Neel, G Paolo Dotto

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sandro GoruppiCutaneous Biology Research Center, Massachusetts General Hospital, 149 Bldg., 13th St. Charlestown, MA 02129, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02125, USA.
Maria-Giuseppina ProcopioDepartment of Biochemistry, University of Lausanne, 155 Chemin des Boveresses, Epalinges 1066, Switzerland.
Seunghee JoCutaneous Biology Research Center, Massachusetts General Hospital, 149 Bldg., 13th St. Charlestown, MA 02129, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02125, USA.
Andrea ClocchiattiCutaneous Biology Research Center, Massachusetts General Hospital, 149 Bldg., 13th St. Charlestown, MA 02129, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02125, USA.
Victor NeelDepartment of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA.
G Paolo DottoCutaneous Biology Research Center, Massachusetts General Hospital, 149 Bldg., 13th St. Charlestown, MA 02129, USA; Department of Biochemistry, University of Lausanne, 155 Chemin des Boveresses, Epalinges 1066, Switzerland. Electronic address: paolo.dotto@unil.ch.
Massachusetts General Hospital · USHarvard University · USUniversity of Lausanne · CH

Funding

GROWTH DIFFERENTIATION CONTROL IN PRIMARY KERATINOCYTES.R01AR039190 · NIAMS · YALE UNIVERSITY · PI DOTTO, GIAN-PAOLO · 1988 to 2021
$9.5M
Dermal fibroblast/ATF3 control of skin homeostasisR01AR064786 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DOTTO, GIAN-PAOLO · 2014 to 2018
$1.9M
NIAMS NIH HHS R01 AR039190NIAMS NIH HHS R01 AR064786
6 · The paper itself

Abstract

The connection between signaling pathways activating cancer-associated fibroblasts (CAFs) remains to be determined. Metabolic alterations linked to autophagy have also been implicated in CAF activation. CSL/RBPJ, a transcriptional repressor that mediates Notch signaling, suppresses the gene expression program(s), leading to stromal senescence and CAF activation. Deregulated GLI signaling can also contribute to CAF conversion. Here, we report that compromised CSL function depends on GLI activation for conversion of human dermal fibroblasts into CAFs, separately from cellular senescence. Decreased CSL upregulates the expression of the ULK3 kinase, which binds and activates GLI2. Increased ULK3 also induces autophagy, which is unlinked from GLI and CAF activation. ULK3 upregulation occurs in the CAFs of several tumor types, and ULK3 silencing suppresses the tumor-enhancing properties of these cells. Thus, ULK3 links two key signaling pathways involved in CAF conversion and is an attractive target for stroma-focused anti-cancer intervention.

Indexed as

AnimalsAutophagyCancer-Associated FibroblastsFemaleFibroblastsFluorescent Antibody TechniqueHumansImmunoglobulin J Recombination Signal Sequence-Binding ProteinMiceProtein Serine-Threonine KinasesSignal TransductionZinc Finger Protein GLI1GLI1 protein, humanImmunoglobulin J Recombination Signal Sequence-Binding ProteinProtein Serine-Threonine KinasesRBPJ protein, humanULK3 protein, humanZinc Finger Protein GLI1autophagyCAFcancer-associated fibroblastcancer stromaCSL/RBPJGLISCCsquamous cell carcinomatumor microenvironmentULK3

Identifiers

PMID28877478
PMCPMC5616185
OpenAlexW2751774580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.